Diseases, Conditions, Syndromes

Active substance raises hopes of curing hepatitis E

An international team of researchers has now found a possible active substance against the virus in the naturally occurring substance silvestrol. The substance inhibited the replication of pathogens both in cell culture and ...


Probable interaction ID'd for PrOD, ribavirin with warfarin

(HealthDay)—There is a probable interaction between paritaprevir/ritonavir/ombitasvir+dasabuvir (PrOD) plus ribavirin with warfarin, according to a case report published online Nov. 3 in the Journal of Clinical Pharmacy ...

Diseases, Conditions, Syndromes

Sofosbuvir tied to rare cases of bradyarrhythmia

(HealthDay)—One of the new, highly effective drugs for treating hepatitis C can cause bradyarrhythmia in some patients, according to a research letter published in the Nov. 5 issue of the New England Journal of Medicine.

Diseases, Conditions, Syndromes

Antiviral favipiravir successfully treats Lassa virus in guinea pigs

Favipiravir, an investigational antiviral drug currently being tested in West Africa as a treatment for Ebola virus disease, effectively treated Lassa virus infection in guinea pigs, according to a new study from National ...

Diseases, Conditions, Syndromes

FDA approves technivie for hepatitis C

(HealthDay)—Technivie (ombitasvir, paritaprevir and ritonavir) has been approved by the U.S. Food and Drug Administration, in tandem with ribavirin, to treat hepatitis C genotype 4 infection among people without cirrhosis ...

page 1 from 4